We are live on ! Find out more
CMTA

Clementia Pharmaceuticals Inc.
CMTA

Delisted

CMTA was delisted on the 17th of April, 2019.

Back to rankings

Fund managers haven’t disclosed any holdings of CMTA yet.

CMTA Hedge Fund Activity: Q2 2019 in Review

0 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Clementia Pharmaceuticals Inc. (CMTA) for Q2 2019, worth a combined $0 — down 100% from $732M a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of CMTA and 0 opened new positions — a net loss of 48 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was OrbiMed, exiting entirely with an estimated $272M sold.

  • 0 institutional investors held Clementia Pharmaceuticals Inc. (CMTA) as of Q2 2019, down from 48 in Q1 2019.
  • Funds reported $0 of Clementia Pharmaceuticals Inc. stock for Q2 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Clementia Pharmaceuticals Inc. positions in Q2 2019 and 48 closed out, a net change of -48 holders.
  • The largest Clementia Pharmaceuticals Inc. seller in Q2 2019 was OrbiMed, an estimated $272M sold.

Based on aggregated 13F filings for Q2 2019.